|
|
SIXTH INTERNATIONAL PHARMACEUTICAL REGULATORY AND COMPLIANCE CONGRESS AND BEST PRACTICES FORUM
May 14 - 16, 2012
|
ONSITE
|
ONLINE
|
Hilton Budapest
Budapest, Hungary |
In your own office or home live via the Internet with 24/7 access for 6 months
|
|
|
|
CONGRESS CO CHAIRS
|
Ann Beasley Bacon
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland |
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA
|
Dominique Laymand, Esq.
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France |
Roeland Van Aelst
Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium
|
|
|
|
KEYNOTE SPEAKERS
|
Richard Bergström
Director General, European Federation of the Pharmaceutical Industries and Associations (EFPIA), Former Director General, LIF Sweden, Brussels, Belgium |
Jose F. Zamarriego Izquierdo
Director Unidad de Supervision Deontologica, FARMAINDUSTRIA, Madrid, Spain |
Aline Lautenberg, JD
Senior Legal Counsel, Eucomed, Brussels, Belgium
|
Bernard Maillet, MD
Member, Flemish Chamber of the Board for Specialists for Pathology, Treasurer, Belgian Association of Specialists (VBS-GBS), Member, EUCOMED's Compliance Panel, Former Secretary General, UEMS and EACCME, Antwerp, Belgium |
Tamara Music
Manager, Influenza Vaccines & Code Compliance, IFPMA, Geneva, Switzerland
|
Marie-Claire Pickaert
Deputy Director General, European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels, Belgium |
Heather Simmonds
Director, Prescription Medicines Code of Practice Authority, London, UK
|
|
|
|
|
FEATURED FACULTY
|
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France |
Ronny Arijs
Vice President Global Sustainability & Chief Compliance Officer, Grunenthal, Member, EFPIA Compliance Workgroup, Former Senior Compliance Manager, GE Healthcare, Brussels, Belgium |
John Auerbach, MA
Partner, Fraud Investigation & Dispute Services, Ernst & Young China, Shanghai, China
|
Dr. Michael Bartke
Director, Compliance Management, Internal Audit & Corporate Compliance, Daiichi Sanky Europe GmbH, Member, EFPIA Compliance Workgroup, Munich, Germany |
Karl Boonen, Esq.
Senior Director Business Practices and Compliance EMEA & Canada, Johnson & Johnson, Antwerp, Belgium |
William E. Buzzeo, MS
Vice President and General Manager - Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA
|
Antonio Cavallaro
Compliance & Internal Auditing Senior Manager, Takeda Italia Farmaceutici, Rome, Italy |
Peter Dieners, Esq.
Partner, Clifford Chance, Dusseldorf, Germany |
Sameh Farag
Associate Vice President Compliance, Intercontinental Zone Corporate Compliance, Sanofi, Paris, France
|
Ildiko Flautner
Compliance Officer Lilly Hungary, Budapest, Hungary |
Daniel Kessler, Esq.
Principal, ITR Group, Former Chief Counsel, International Trade Controls, Pfizer, Tel Aviv, Israel |
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
|
Nieves Liste, MBA
Global Business Compliance Director, Covidien, Barcelona, Spain |
Paul J. Melling, Esq.
Founding Partner, Baker & McKenzie - CIS, Limited, Moscow, Russia |
Marc L. Miller, CPA
Partner, KPMG LLP, New York, NY, USA
|
Kirti Narsai, MSc(Pharm), MBA
Head: Scientific and Regulatory Affairs, Pharmaceutical Industry Association of South Africa, Vorna Valley, South Africa |
Laura Nassar
Pharma Compliance Officer, Turkey Middle East Africa, Johnson & Johnson, Beirut, Lebanon |
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA
|
Vivian Robinson, Esq.
Partner, McGuireWoods, Former General Counsel of the UK Serious Fraud Office, Former Head, QEB Hollis Whiteman Chambers, Recorder of the Crown Court and Treasurer of Inner Temple, London, UK |
Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim Relationship Management, Paris, France |
Yuet-Ming Tham, Esq.
Partner and Head, Regulatory, Compliance, & Investigations Group, Asia, DLA Piper LLP, Hong Kong
|
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division, United States Department of Justice, Washington, DC, USA |
Madina Torchinova, Esq.
Regional Compliance Officer CEE, Sandoz, Former Director Legal and Regulatory Affairs, Association of International Pharmaceutical Manufacturers (AIPM), Russia, Munich, Germany
|
Mariusz Witalis
Partner, Fraud Investigation and Dispute Services, Ernst & Young LLP, Warsaw, Poland |
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
|
INTERNATIONAL PHARMA CONGRESS PLANNING COMMITTEE
|
Ann Beasley Bacon
Global Compliance Officer, Novartis Pharma AG, Basel, Switzerland (Co chair)
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company, Indianapolis, IN, USA (Co chair)
Dominique Laymand, Esq.
Executive Director Compliance & Ethics EMEA (Europe, Middle-East, Africa, Russia and Turkey), Bristol-Myers Squibb, Paris, France (Co chair)
Roeland Van Aelst
Vice President EMEA & Canada, J&J Office Health Care Compliance & Privacy, Johnson&Johnson, Brussels, Belgium (Co chair)
Ted Acosta, Esq.
Principal, Ernst & Young LLP, Former Senior Counsel, Office of Inspector General, US Department of Health and Human Services, New York, NY, USA and Paris, France
Ronny Arijs
Vice President Global Sustainability & Chief Compliance Officer, Grunenthal, Former Senior Compliance Manager GE Healthcare, Brussels, Belgium
Wayne Baker
Sr. Vice President, Advanced Health Media LLC, Bridgewater, NJ, USA
Bulent Becan
Managing Partner, Atuva Management Consultancy and Trade Ltd., Consultant in Ethics Issues, Turkish Research Based Pharmaceutical Companies Association (AIFD), Istanbul, Turkey
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP, Former Special Counsel for Healthcare Fraud, and Chief Privacy Officer, US Department of Justice, Washington, DC, USA
Hugh C. Bigwood
Ethics and Compliance Officer, International Operations, Abbott Laboratories, Horsham, West Sussex, United Kingdom
Antonio Cavallaro
Compliance & Internal Auditing Senior Manager, Takeda Italia Farmaceutici, Rome, Italy
Peter Dieners, Esq.
Partner, Clifford Chance, Düsseldorf, Germany
Pierre E. Dupourque
Regional Compliance Director, Corporate Compliance, International Investigations and Programs, Pfizer Inc, Mannheim, Germany
|
Sue Egan
Director and Principal Consultant, Sue Egan Associates, Former Vice President Compliance, AstraZeneca, Great Missenden, Buckinghamshire, UK
Annette Schutt Fiig
Director, Risk Office, Novo Nordisk, Copenhagen, Denmark
Gerard Geneen
Vice President, Compliance Officer, Pharma Europe, GlaxoSmithKline, Brentford, Middlesex, United Kingdom
Sameh Farag
Associate Vice President Compliance, Intercontinental Zone Corporate Compliance, Sanofi, Paris, France
Gary F. Giampetruzzi, Esq.
Vice President and Assistant General Counsel, Head of Government Investigations, Pfizer Inc, New York, NY, USA
Keith M. Korenchuk, JD, MPH
Partner, Arnold & Porter LLP, Washington, DC, USA
Marc L. Miller
Partner, KPMG LLP, New York, NY, USA
Maxine Nogard
Senior Director, Global Corporate Compliance, Biogen Idec Inc., Weston, MA, USA
Dave O'Shaunessy
Vice President Global Compliance Strategy and Implementation, AstraZeneca, Former Vice President and Compliance Officer, Emerging Markets & Asia Pacific, GlaxoSmithKline, London, United Kingdom
Brian Riewerts
Partner, Global Pharmaceuticals and Life Sciences, PricewaterhouseCoopers LLP, Baltimore, MD, USA
Guillaume Roussel
Vice President, Compliance Solutions EMEA, Cegedim, Paris, France
Joseph B. Tompkins, Jr.
Partner, Sidley Austin LLP, Former Deputy Chief of the Fraud Section, Criminal Division of the United States Department of Justice, Washington, DC, USA
Paul B. Woods, BPharm, MA, MRPharmS
Independent Consultant, Former Global Compliance Policy Director, AstraZeneca, Macclesfield, Cheshire, UK
Elisabethann Wright, Esq.
Partner, Hogan Lovells, Former, Senior Legal Officer and Hearing Officer, EFTA Surveillance Authority, Brussels, Belgium
|
|
|
|
|
|
|
THE INTERNATIONAL PHARMA CONGRESS IS DEDICATED TO THE MEMORY OF
|
Gabor Danielfy
Vice-President & Global Compliance Officer, Sanofi
Former Senior Director Healthcare Compliance Europe, Middle East & Africa, Johnson & Johnson
Former Senior Director Global Compliance & Business Practices EMEA, Schering Plough Corp
Former General Manager Andean Region, Bayer Pharmaceuticals
Founder, ETHICS (EMEA Think-tank on Healthcare Integrity and Compliance Strategies)
Member, EFPIA Code Steering Group
Member, IFPMA Code Network
Co-Chair, International Pharma Compliance Congress
Paris, France
|
|
CLICK HERE TO VIEW GABOR'S COMMENTS ON THE ROLE OF COMPLIANCE IN THE GLOBAL PHARMACEUTICAL ENTERPRISE
|
|
|
|
SPEAKER PRESENTATION PROPOSALS
|
Speaker/Presentation Proposals for the International Pharma Congress May Be Submitted Through Our Online Form
- Click Here -
|
|
|
|
ONLINE ATTENDEE LOG IN
|
Attendees registered for the International Pharma Congress Online Video/Audio Archive - click here to log in.
|
|
|
|
SPONSORED BY:
|
|
The Pharmaceutical Compliance Forum (PCF) is a coalition of senior compliance professionals and legal counsel from more than 50 of the largest research-based pharmaceutical manufacturers. The PCF was founded in early-1999 by compliance professionals from the pharmaceutical industry to promote effective corporate compliance programs. The members meet twice a year, for two days, focusing on open and informal sharing of compliance information, best practices, and current developments in the field, and sponsors a two-day international compliance congress in the Spring and a three-day US compliance congress each Fall.
|
|
|
MEDIA PARTNERS
|
|
|
GRANTORS:
|
|
PLATINUM
|
|
|
GOLD
|
|
|
SILVER
|
|
|
BRONZE
|
|
|
PAST INTERNATIONAL PHARMA CONGRESSES
|
2007 - Brussels, Belgium
2008 - Paris, France
2009 - Rome, Italy
2010 - Berlin, Germany
2011 - Istanbul, Turkey
2011 - Singapore
|
|
|
FOLLOW INTERNATIONAL PHARMA CONGRESS ON
|
|
|
|
|
|
|
